1 option
Novo Nordisk surges to success, but will it survive unscathed? / Simran Mehta.
- Format:
- Book
- Author/Creator:
- Mehta, Simran, author.
- Series:
- SAGE business cases.
- SAGE business cases
- Language:
- English
- Subjects (All):
- Novo Nordisk--Management--Case studies.
- Novo Nordisk.
- Pharmaceutical industry--Denmark--Case studies.
- Pharmaceutical industry.
- Denmark--Economic conditions--Case studies.
- Denmark.
- Physical Description:
- 1 online resource : illustrations.
- Place of Publication:
- SAGE Publications, Inc
- London : SAGE Publications: SAGE Business Cases Originals, 2023.
- Summary:
- Novo Nordisk, a pharmaceutical company based in Denmark, has boosted its home country’s financial state thanks to its widely publicized weight loss drugs, Wegovy and Ozempic. While consumer response to the medicines has been overwhelming, it remains to be seen whether the company can sustain its massive growth in the long term. This case study examines how Novo Nordisk could impact not only the pharmaceutical world but also Denmark’s overall economy.
- Notes:
- Description based on XML content.
- ISBN:
- 1-0719-4094-5
- 9781071940945
- OCLC:
- 1409338613
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.